- Taiwanese firm set to enter US & worldwide 3D medical printing markets
- Sputnik V vaccine receives authorization in India
- Australia reviews all reports of blood clots following AstraZeneca vaccine
- An Asia-Pacific perspective on resilience in the biopharma industry
- Third-party ingredient verification key for drug supply chain
- Australia approves wider storage conditions for Pfizer COVID-19 vaccine
- HEC Pharm increases biopharmaceutical production capacity in China
- New Zealand joins hands with WHO to eliminate health inequities
- Singapore enhances neutralizing antibody testing service
- Korea pushes R&D of infectious disease therapeutics and vaccines
- Korea’s SNU Medicine bags $50K ATMI Grant by Terumo
- CAR-T therapy leads Singapore medical tourism within APAC
- Celonic and CureVac to manufacture 100 Million doses of CVnCoV
- Sanofi invests in Asia's first digitally-enabled vaccine production center in Singapore
-
Specials | 28 February 2021 | Influencers
1.What have been your key contributions within the organization towards fighting covid-19? The curren...Read more
Singapore | 12 February 2021 | News
Singapore discovers brain enzyme that activates dormant neural stem cells
Singapore's Duke-NUS Medical School researchers studying an enzyme in fruit fly larvae have found that it...Read more
-
Europe | 17 February 2021 | News
Merck designs sustainability framework offering data-driven insights
Merck, a leading science and technology company, has launched an enhanced Design for Sustainability (Df...Read more
-
World | 12 February 2021 | News
GenScript receives FDA EUA to use cPass test in convalescent plasma screening
GenScript USA Inc., the world's leading life science research tools and services provider, announced today tha...Read more
World | 10 February 2021 | News
Globally 128 million COVID-19 vaccine doses administered so far, updates WHO
WHo at a media briefing on Feb 10, 2021, updated that globally around 128 million vaccine doses administered s...Read more
-
Australia | 12 February 2021 | News
Australia offers revolutionary new treatment for antibiotic resistance
SuperTrans Medical (STM), a biopharmaceutical company developing novel antibiotics that target difficult-to-tr...Read more
-
World | 11 January 2021 | News
PerkinElmer to acquire Oxford Immunotec for $591M
PerkinElmer, Inc. and Oxford Immunotec Global PLC have reached an agreement on terms under which Per...Read more
BIG PHARMA RE-HASH MEDICAL MARIJUANA
Known to the world by many names, Marijuana, Cannabis, MJ, Pot, weed or Ganjika in Sanskrit and Ganja in Hindi, this ancient plant has been known to the ancient Indians and Chinese for its medicinal benefits. Ayurvedic texts known as Samhitas have extolled the many benefits of this widely available green wonder. Yet, due to misconceptions, willful or otherwise had shrouded it for many centuries. While there are numerous medicinal properties that can be applied, misuse of the plant could also have disastrous consequences, especially if used as an addictive derivative. The global medical cannabis market is set to reach $3.2 billion by 2025, according to GlobalData. With big pharma taking notice and interest in the sector, the cannabis industry is at the brink of a revolution. BioSpectrum deep dives in to the fascination of big pharma in the cannabis space, how will this disrupt the cannabis industry and most importantly how the pharmaceutical cannabis sector should be regulated?
For Feedback Email Us : communications@biospectrumasia.com
